Mass spectrometric determination of early and advanced glycation in biology
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Protein glycation in biological systems occurs predominantly on lysine, arginine and N-terminal residues of proteins. Major quantitative glycation adducts are found at mean extents of modification of 1-5 mol percent of proteins. These are glucose-derived fructosamine on lysine and N-terminal residues of proteins, methylglyoxal-derived hydroimidazolone on arginine residues and N(ε)-carboxymethyl-lysine residues mainly formed by the oxidative degradation of fructosamine. Total glycation adducts of different types are quantified by stable isotopic dilution analysis liquid chromatography-tandem mass spectrometry (LC-MS/MS) in multiple reaction monitoring mode. Metabolism of glycated proteins is followed by LC-MS/MS of glycation free adducts as minor components of the amino acid metabolome. Glycated proteins and sites of modification within them - amino acid residues modified by the glycating agent moiety - are identified and quantified by label-free and stable isotope labelling with amino acids in cell culture (SILAC) high resolution mass spectrometry. Sites of glycation by glucose and methylglyoxal in selected proteins are listed. Key issues in applying proteomics techniques to analysis of glycated proteins are: (i) avoiding compromise of analysis by formation, loss and relocation of glycation adducts in pre-analytic processing; (ii) specificity of immunoaffinity enrichment procedures, (iii) maximizing protein sequence coverage in mass spectrometric analysis for detection of glycation sites, and (iv) development of bioinformatics tools for prediction of protein glycation sites. Protein glycation studies have important applications in biology, ageing and translational medicine - particularly on studies of obesity, diabetes, cardiovascular disease, renal failure, neurological disorders and cancer. Mass spectrometric analysis of glycated proteins has yet to find widespread use clinically. Future use in health screening, disease diagnosis and therapeutic monitoring, and drug and functional food development is expected. A protocol for high resolution mass spectrometry proteomics of glycated proteins is given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
ProteoWizard: open source software for rapid proteomics tools development
Kessner, D., Chambers, M., Burke, R., Agus, D., & Mallick, P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn323 · Cited by 2,024
Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease
Rabbani, N., & Thornalley, P. J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.140 · Cited by 353
Self-citationDicarbonyl proteome and genome damage in metabolic and vascular disease
Rabbani, N., & Thornalley, P. J. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140018 · Cited by 140
Self-citationThornalley, P. J., & Rabbani, N. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.03.025 · Cited by 133 · cited 2×
“Analysis of protein glycation is compromised by use of heating and high pH in pre-analytic processing for mass spectrometric analysis [2].”
BackgroundSelf-citation
Research works printed but not linked: 110
- Rabbani N., Thornalley P.J.: Glycation research in amino acids: a place to call home. Amino Acids. 42(4), 1087–1096 (2012) · DOI
- Thornalley P.J., Battah S., Ahmed N., Karachalias N., Agalou S., Babaei-Jadidi R., Dawnay A.: Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem. J. 375(3), 581–592 (2003) · DOI · Paper page
- Ahmed N., Argirov O.K., Minhas H.S., Cordeiro C.A., Thornalley P.J.: Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatisation by aminoquinolyl-N-hydroxysuccimidyl-carbamate and application to Nε-carboxymethyl-lysine- and Nε-(1-carboxyethyl)lysine-modified albumin. Biochem. J. 364(1), 1–14 (2002) · DOI · Paper page
- Rabbani N., Thornalley P.J.: Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids. 42(4), 1133–1142 (2012) · DOI · Paper page
- Baynes J.W., Thorpe S.R., Murtiashaw M.H.: Nonenzymatic glucosylation of lysine residues in albumin. Methods Enzymol. 106, 88–98 (1984) · DOI
- Smith P.R., Thornalley P.J.: Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. (Studies with the model fructosamine, N -(1-deoxy-D-fructose-1-yl)hippuryl-lysine). Eur J Biochem. 210(3), 729–739 (1992) · DOI · Paper page
- Calvo C., Ulloa N., Campos M., Verdugo C., Ayrault-Jarrier M.: The preferential site of non-enzymatic glycation of human apolipoprotein A-I in vivo. Clin Chim Acta. 217(2), 193–198 (1993) · doi:10.1016/0009-8981(93)90165-z
- Shuvaev V.V., Fujii J., Kawasaki Y., Itoh H., Hamaoka R., Barbier A., Ziegler O., Siest G., Taniguchi N.: Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site. Biochim Biophys Acta. 1454(3), 296–308 (1999) · DOI
- Fujita T., Suzuki K., Tada T., Yoshihara Y., Hamaoka R., Uchida K., Matuo Y., Sasaki T., Hanafusa T., Taniguchi N.: Human erythrocyte Bisphosphoglycerate mutase: inactivation by glycation in vivo and in vitro. J Biochem. 124(6), 1237–1244 (1998) · doi:10.1093/oxfordjournals.jbchem.a022243
- Acosta J., Hettinga J., Flückiger R., Krumrei N., Goldfine A., Angarita L., Halperin J.: Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci U S A. 97(10), 5450–5455 (2000) · DOI · Paper page
- Niemann M.A., Bhown A.S., Miller E.J.: The principal site of glycation of human complement factor B. Biochem J. 274(2), 473–480 (1991) · doi:10.1042/bj2740473
- O’Harte F.P.M., Abdel-Wahab Y.H.A., Conlon J.M., Flatt P.R.: Amino terminal glycation of gastric inhibitory polypeptide enhances its insulinotropic action on clonal pancreatic B-cells. Biochim Biophys Acta. 1425(2), 319–327 (1998) · DOI
- O'Harte F.P.M., Abdel-Wahab Y.H.A., Conlon J.M., Flatt P.R.: Glycation of glucagon-like peptide-1(7–36)amide: characterization and impaired action on rat insulin secreting cells. Diabetologia. 41(10), 1187–1193 (1998) · DOI
- Zhang X., Medzihradszky K.F., Cunningham J., Lee P.D.K., Rognerud C.L., Ou C.N., Harmatz P., Witkowska H.E.: Characterization of glycated hemoglobin in diabetic patients: usefulness of electrospray mass spectrometry in monitoring the extent and distribution of glycation. J ChromatogrB. 759(1), 1–15 (2001) · DOI
- Coletta M., Amiconi G., Bellelli A., Bertollini A., Čarsky J., Castagnola M., Condò S., Brunori M.: Alteration of T-state binding properties of naturally glycated hemoglobin, HbA1c. J Mol Biol. 203(1), 233–239 (1988) · DOI
- Wang S.H., Wang T.F., Wu C.H., Chen S.H.: In-depth comparative characterization of hemoglobin glycation in normal and diabetic bloods by LC-MSMS. J Amer Soc Mass Spectrometry. 25(5), 758–766 (2014) · DOI
- O'Harte F.P.M., Højrup P., Barnett C.R., Flatt P.R.: Identification of the site of glycation of human insulin. Peptides. 17(8), 1323–1330 (1996) · DOI
- Miyata T., Inagi R., Wada Y., Ueda Y., Iida Y., Takahashi M., Taniguchi N., Maeda K.: Glycation of human beta 2 -microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites. Biochemistry. 33(40), 12215–12221 (1994) · DOI
- Barnaby O.S., Cerny R.L., Clarke W., Hage D.S.: Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI–TOF MS. Clin Chim Acta. 412(17–18), 1606–1615 (2011) · DOI
- Rabbani N., AntonySunil A., Rossing K., Rossing P., Tarnow L., Parving H.H., Thornalley P.J.: Effect of Irbesartan treatment on plasma and urinary protein glycation, oxidation and nitration markers in patients with type 2 diabetes and microalbuminuria. Amino Acids. 42(5), 1627–1639 (2011) · DOI
- Arai K., Maguchi S., Fujii S., Ishibashi H., Oikawa K., Taniguchi N.: Glycation and inactivation of human Cu-Zn-superoxide dismutase - identification of the invitro glycated sites. J Biol Chem. 262(35), 16969–16972 (1987) · DOI · Paper page
- Abraham E.C., Cherian M., Smith J.B.: Site selectivity in the glycation of αA-crystallin and αB-Crystallins by glucose. Biochem Biophys Res Commun. 201(3), 1451–1456 (1994) · doi:10.1006/bbrc.1994.1866
- Casey E.B., Zhao H.R., Abraham E.C.: Role of glycine 1 and lysine 2 in the glycation of bovine g B-crystallin. J.Biol.Chem. 270(35), 20781–20786 (1995) · doi:10.1074/jbc.270.35.20781
- Baldwin J.S., Lee L., Leung T.K., Muruganandam A., Mutus B.: Identification of the site of nonenzymatic glycation of glutathione-peroxidase - rationalization of the glycation-related catalytic alterations on the basis of 3-dimensional protein-structure. Biochim Biophys Acta. 1247(1), 60–64 (1995) · doi:10.1016/0167-4838(94)00202-r
- Guedes S., Vitorino R., Domingues M.R.M., Amado F., Domingues P.: Mass spectrometry characterization of the glycation sites of bovine insulin by tandem mass spectrometry. J Am Soc Mass Spectrom. 20(7), 1319–1326 (2009) · DOI
- Swamy Mruthinti S., Schey K.L.: Mass spectroscopic identification of in vitro glycated sites of MIP. Curr Eye Res. 16(9), 936–941 (1997) · doi:10.1076/ceyr.16.9.936.5037
- Watkins N.G., Thorpe S.R., Baynes J.W.: Glycation of amino groups in protein. (Studies on the specificity of modification of RNase by glucose). J Biol Chem. 260(19), 10629–10636 (1985) · DOI · Paper page
- Frolov A., Hoffmann P., Hoffmann R.: Fragmentation behavior of glycated peptides derived from D-glucose, D-fructose and D-ribose in tandem mass spectrometry. J Mass Spectrom. 41(11), 1459–1469 (2006) · DOI
- Reiser K.M., Amigable M., Last J.A.: Nonenzymatic glycation of type I collagen (the effects of aging on preferential glycation sites. J.Biol.Chem. 267(34), 24207–24216 (1992) · DOI
- Takahashi M., Lu Y.-b., Myint T., Fujii J., Wada Y., Taniguchi N.: In vivo glycation of aldehyde reductase, a major 3-deoxyglucosone reducing enzyme: identification of glycation sites. Biochemistry. 34(4), 1433–1438 (1995) · DOI
- Ahmed M.U., Thorpe S.R., Baynes J.W.: Identification of Nε-carboxymethyl-lysine as a degradation product of fructoselysine in glycated protein. J Biol Chem. 261(11), 4889–4894 (1986) · DOI · Paper page
- Wells-Knecht M.C., Thorpe S.R., Baynes J.W.: Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry. 34(46), 15134–15141 (1995) · DOI · Paper page
- Anderson M.M., Requena J.R., Crowley J.R., Thorpe S.R., Heinecke J.W.: The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest. 104(1), 103–113 (1999) · DOI · Paper page
- Ahmed N., Babaei-Jadidi R., Howell S.K., Beisswenger P.J., Thornalley P.J.: Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia. 48(8), 1590–1603 (2005) · DOI · Paper page
- Babaei-Jadidi R., Karachalias N., Kupich C., Ahmed N., Thornalley P.J.: High dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia. 47, 2235–2246 (2004) · DOI
- Karachalias N., Babaei-Jadidi R., Rabbani N., Thornalley P.J.: Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes. Diabetologia. 53(7), 1506–1516 (2010) · DOI
- Ahmed N., Thornalley P.J., Dawczynski J., Franke S., Strobel J., Stein G., Haik Jr. G.M.: Methylglyoxal-derived hydroimidazolone advanced glycation endproducts of human lens proteins. Investig Ophthalmol Vis Sci. 44(12), 5287–5292 (2003) · DOI · Paper page
- Lo T.W.C., Selwood T., Thornalley P.J.: Reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochem Pharmacol. 48(10), 1865–1870 (1994) · DOI
- Gallet X., Charloteaux B., Thomas A., Braseur R.: A fast method to predict protein interaction sites from sequences. JMolBiol. 302(4), 917–926 (2000)
- Godfrey L., Yamada-Fowler N., Smith J.A., Thornalley P.J., Rabbani N.: Arginine-directed glycation and decreased HDL plasma concentration and functionality. Nutrition and diabetes. 4, e134 (2014) · DOI · Paper page
- Rabbani N., Godfrey L., Xue M., Shaheen F., Geoffrion M., Milne R., Thornalley P.J.: Conversion of low density lipoprotein to the pro-atherogenic form by methylglyoxal with increased arterial proteoglycan binding and aortal retention. Diabetes. 60(7), 1973–1980 (2011) · DOI · Paper page
- Dobler D., Ahmed N., Song L.J., Eboigbodin K.E., Thornalley P.J.: Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes. 55(7), 1961–1969 (2006) · DOI · Paper page
- Pedchenko V.K., Chetyrkin S.V., Chuang P., Ham A.J., Saleem M.A., Mathieson P.W., Hudson B.G., Voziyan P.A.: Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy. Diabetes. 54(10), 2952–2960 (2005) · DOI · Paper page
- Gangadhariah M.H., Wang B.L., Linetsky M., Henning C., Spanneberg R., Glomb M.A., Nagaraj R.H.: Hydroimidazolone modification of human alpha A-crystallin: effect on the chaperone function and protein refolding ability. Biochim Biophys Acta. 1802(4), 432–441 (2010) · DOI
- Kiselar J.G., Wang X., Dubyak G.R., El Sanadi C., Ghosh S.K., Lundberg K., Williams W.M.: Modification of β-Defensin-2 by Dicarbonyls methylglyoxal and glyoxal inhibits antibacterial and chemotactic function in vitro. PLoS One. 10(8), e0130533 (2015) · DOI
- Lund T., Svindland A., Pepaj M., Jensen A.B., Berg J.P., Kilhovd B., Hanssen K.F.: Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans. Diabetes Vascular Disease Research. 8(4), 284–294 (2011) · DOI
- Oya-Ito T., Naito Y., Takagi T., Handa O., Matsui H., Yamada M., Shima K., Yoshikawa T.: Heat-shock protein 27 (Hsp27) as a target of methylglyoxal in gastrointestinal cancer. Biochim Biophys Acta. 1812(7), 769–781 (2011) · DOI
- Chen Y., Ahmed N., Thornalley P.J.: Peptide mapping of human hemoglobin modified minimally by methylglyoxal in vitro. AnnNYAcadSci. 1043, 905 (2005) · doi:10.1196/annals.1333.119
- Gao Y., Wang Y.: Site-selective modifications of arginine residues in human hemoglobin induced by methylglyoxal. Biochemistry. 45(51), 15654–15660 (2006) · DOI
- Thangarajah H., Yao D.C., Chang E.I., Shi Y.B., Jazayeri L., Vial I.N., Galiano R.D., Du X.L., Grogan R., Galvez M.G., Januszyk M., Brownlee M., Gurtner G.C.: The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A. 106(32), 13505–13510 (2009) · DOI · Paper page
- Oliveira L., Lages A., Gomes R., Neves H., Familia C., Coelho A., Quintas A.: Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation. BMC Biochem. 12(1), 41 (2011) · DOI
- Chumsae C., Gifford K., Lian W., Liu H., Radziejewski C.H., Zhou Z.S.: Arginine modifications by methylglyoxal: discovery in a recombinant monoclonal antibody and contribution to acidic species. Anal Chem. 85(23), 11401–11409 (2013) · DOI
- Kinsky O.R.: Dicarbonyl Protein Adduction: Plasminogen as a Target and Metformin as a Scavenging Therapeutic in Type 2 Diabetes. PhD thesis. PhD thesis. University of Arizona, Tucson, USA (2014)
- Queisser M.A., Yao D., Geisler S., Hammes H.P., Lochnit G., Schleicher E.D., Brownlee M., Preissner K.T.: Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes. 59(3), 670–678 (2010) · DOI · Paper page
- Brock J.W.C., Cotham W.E., Thorpe S.R., Baynes J.W., Ames J.M.: Detection and identification of arginine modifications on methylglyoxal-modified ribonuclease by mass spectrometric analysis. J Mass Spectrom. 42(1), 89–100 (2007) · DOI · Paper page
- Cotham W.E., Metz T.O., Ferguson P.L., Brock J.W.C., Hinton D.J.S., Thorpe S.R., Baynes J.W., Ames J.M.: Proteomic analysis of arginine adducts on glyoxal-modified ribonuclease. Mol Cell Proteomics. 3(12), 1145–1153 (2004) · DOI
- Kimzey, M.J., Yassine, H.N., Riepel, B.M., Tsaprailis, G., Monks, T.J., Lau, S.S.: New site(s) of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism. Chem Biol Interact 192(1–2), 122–128 (2011). · DOI
- Ahmed N., Dobler D., Dean M., Thornalley P.J.: Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J. Biol. Chem. 280(7), 5724–5732 (2005) · DOI · Paper page
- Yao D., Taguchi T., Matsumura T., Pestell R., Edelstein D., Giardino I., Suske G., Rabbani N., Thornalley P.J., Sarthy V.P., Hammes H.P., Brownlee M.: High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem. 282(42), 31038–31045 (2007) · DOI · Paper page
- Agalou S., Ahmed N., Babaei-Jadidi R., Dawnay A., Thornalley P.J.: Profound mishandling of protein glycation degradation products in uremia and dialysis. J Amer Soc Nephrol. 16(5), 1471–1485 (2005) · DOI · Paper page
- Teerlink T., Barto R., ten Brink H.J., Schalkwijk C.G.: Measurement of Nî-(carboxymethyl)lysine and Nî-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry. Clin Chem. 50(7), 1222–1228 (2004) · DOI · Paper page
- Rabbani N., Shaheen F., Anwar A., Masania J., Thornalley P.J.: Assay of methylglyoxal-derived protein and nucleotide AGEs. Biochem Soc Trans. 42(2), 511–517 (2014) · DOI · Paper page
- Fan X., Sell D.R., Zhang J., Nemet I., Theves M., Lu J., Strauch C., Halushka M.K., Monnier V.M.: Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: a comparative analysis. Free Radic Biol Med. 49(5), 847–856 (2010) · DOI · Paper page
- Henle T., Walter H., Klostermeyer H.: Evaluation of the extent of the early Maillard-reaction in milk products by direct measurement of the Amadori-product lactuloselysine. ZLebensmUntersForsch. 193, 119–122 (1991)
- Rabbani N., Varma Chittari M., Bodmer C.W., Zehnder D., Ceriello A., Thornalley P.J.: Increased glycation and oxidative damage to apolipoprotein B100 of LDL in patients with type 2 diabetes and effect of metformin. Diabetes. 59(4), 1038–1045 (2010) · DOI · Paper page
- Ahmed N., Thornalley P.J.: Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatisation with aminoquinolyl-N-hydroxysuccimidyl-carbamate and intrinsic fluorescence. Biochem J. 364, 15–24 (2002) · DOI · Paper page
- Glomb M.A., Pfahler C.: Amides are novel protein modifications formed by physiological sugars. J Biol Chem. 276(45), 41638–41647 (2001) · DOI · Paper page
- Scheffer P.G., Bakker S.J.L., Heine R.J., Teerlink T.: Measurement of low-density lipoprotein particle size by high-performance gel-filtration chromatography. Clin Chem. 43(10), 1904–1912 (1997) · DOI
- Krause R., Knoll K., Henle T.: Studies on the formation of furosine and pyridosine during acid hydrolysis of different Amadori products of lysine. Eur Food Res Technol. 216(4), 277–283 (2003) · DOI
- Troise A.D., Fiore A., Wiltafsky M., Fogliano V.: Quantification of N epsilon-(2-furoylmethyl)-L-lysine (furosine), N epsilon-(carboxymethyl)-L-lysine (CML), N epsilon-(carboxyethyl)-L-lysine (CEL) and total lysine through stable isotope dilution assay and tandem mass spectrometry. Food Chem. 188, 357–364 (2015) · DOI
- Gupta N., Pevzner P.A.: False discovery rates of protein identifications: a strike against the two-peptide rule. J Proteome Res. 8(9), 4173–4181 (2009) · DOI · Paper page
- Ong S.-E., Mann M.: A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc. 1(6), 2650–2660 (2007) · DOI · Paper page
- Noirel J., Evans C., Salim M., Mukherjee J., Ow S.Y., Pandhal J., Pham T.K., Biggs C.A., Wright P.C.: Methods in quantitative proteomics: setting iTRAQ on the right track. Curr Probl Dermatol. 8(1), 17–30 (2011)
- Nahnsen S., Bielow C., Reinert K., Kohlbacher O.: Tools for label-free peptide quantification. Mol Cell Proteomics. 12(3), 549–556 (2013) · DOI · Paper page
- Kimzey M.J., Kinsky O.R., Yassine H.N., Tsaprailis G., Stump C.S., Monks T.J., Lau S.S.: Site specific modification of the human plasma proteome by methylglyoxal. Toxicol Appl Pharmacol. 289(2), 155–162 (2015) · DOI
- Brede C., Hop B., Jørgensen K., Skadberg Ø.: Measurement of glycated albumin in serum and plasma by LC-MS/MS. Scand J Clin Lab Invest. 76(3), 195–201 (2016) · DOI
- Liebler D.C., Zimmerman L.J.: Targeted quantitation of proteins by mass spectrometry. Biochemistry. 52(22), 3797–3806 (2013) · DOI · Paper page
- Nagaraj N., Kulak N.A., Cox J., Neuhauser N., Mayr K., Hoerning O., Vorm O., Mann M.: System-wide perturbation analysis with nearly complete coverage of the yeast proteome by single-shot ultra HPLC runs on a bench top Orbitrap. Mol Cell Proteomics. 11(3), 11 (2012) · DOI · Paper page
- Meyer J.G.: In silico proteome cleavage reveals iterative digestion strategy for high sequence coverage. ISRN Computational Biol. 2014, 7 (2014) · DOI
- Johansen M.B., Kiemer L., Brunak S.: Analysis and prediction of mammalian protein glycation. Glycobiology. 16(9), 844–853 (2006) · DOI · Paper page
- Zhang Q., Monroe M.E., Schepmoes A.A., Clauss T.R.W., Gritsenko M.A., Meng D., Petyuk V.A., Smith R.D., Metz T.O.: Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects. J Proteome Res. 10(7), 3076–3088 (2011) · DOI
- Anandakrishnan R., Aguilar B., Onufriev A.V.: H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res. 40(W1), W537–W541 (2012) · DOI · Paper page
- Harris R., Patel S.U., Sadler P.J., Viles J.H.: Observation of albumin resonances in proton nuclear magnetic resonance spectra of human blood plasma: N-terminal assignments aided by use of modified recombinant albumin. Analyst. 121(7), 913–922 (1996) · doi:10.1039/an9962100913
- Venkatraman J., Aggarwal K., Balaram P.: Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement. Chem Biol. 8(7), 611–625 (2001) · DOI
- Schleicher E., Wieland O.H.: Kinetic analysis of glycation as a tool for assesing the half-life of proteins. Biochim Biophys Acta. 884(1), 199–205 (1986) · DOI
- Wang Y., Yu H., Shi X., Luo Z., Lin D., Huang M.: Structural mechanism of ring-opening reaction of glucose by human serum albumin. J Biol Chem. 288(22), 15980–15987 (2013) · DOI
- Delpierre G., Rider M.H., Collard F., Stroobant V., Vanstapel F., Santos H., Van Schaftingen E.: Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes. 49(10), 1627–1634 (2000) · DOI · Paper page
- Delpierre G., Vertommen D., Communi D., Rider M.H., Van Schaftingen E.: Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin. J. Biol. Chem. 279(26), 27613–27620 (2004) · DOI · Paper page
- Nesvizhskii A.I., Keller A., Kolker E., Aebersold R.: A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem. 75(17), 4646–4658 (2003) · DOI · Paper page
- Roberts N.B., Amara A.B., Morris M., Green B.N.: Long-term evaluation of electrospray ionization mass spectrometric analysis of glycated hemoglobin. Clin Chem. 47(2), 316–321 (2001) · DOI
- Thornalley P.J., Argirova M., Ahmed N., Mann V.M., Argirov O.K., Dawnay A.: Mass spectrometric monitoring of albumin in uraemia. Kidney Int. 58(5), 2228–2234 (2000) · DOI
- Jerić I., Versluis C., Horvat Š., Heck A.J.R.: Tracing glycoprotein structures: electrospray ionization tandem mass spectrometric analysis of sugar–peptide adducts. J Mass Spectrom. 37(8), 803–811 (2002) · DOI
- Horvat Š., Jakas A.: Peptide and amino acid glycation: new insights into the Maillard reaction. J Pept Sci. 10(3), 119–137 (2004) · DOI
- Mennella C., Visciano M., Napolitano A., Del Castillo M.D., Fogliano V.: Glycation of lysine-containing dipeptides. J Pept Sci. 12(4), 291–296 (2006) · DOI
- Zhang Q.B., Frolov A., Tang N., Hoffmann R., van de Goor T., Metz T.O., Smith R.D.: Application of electron transfer dissociation mass spectrometry in analyses of non-enzymatically glycated peptides. Rapid Commun Mass Spectrom. 21(5), 661–666 (2007) · DOI
- Cai J., Hurst H.E.: Identification and quantitation of N-(carboxymethyl)valine adducts in hemoglobin by gas chromatography/mass spectrometry. J Mass Spectrom. 34(5), 537–543 (1999) · DOI
- Brock J.W.C., Hinton D.J.S., Cotham W.E., Metz T.O., Thorpe S.R., Baynes J.W., Ames J.M.: Proteomic analysis of the site specificity of glycation and Carboxymethylation of ribonuclease. J Proteome Res. 2(5), 506–513 (2003) · DOI · Paper page
- Zhang Q., Tang N., Brock J.W.C., Mottaz H.M., Ames J.M., Baynes J.W., Smith R.D., Metz T.O.: Enrichment and analysis of Nonenzymatically glycated peptides: boronate affinity chromatography coupled with electron-transfer dissociation mass spectrometry. J Proteome Res. 6(6), 2323–2330 (2007) · DOI · Paper page
- Myint T., Hoshi S., Ookawara T., Miyazawa N., Keiichiro M., Suzuki K., Taniguchi N.: Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG. Biochim Biophys Acta. 1272, 73–79 (1995) · DOI
- Thornalley P.J., Langborg A., Minhas H.S.: Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J. 344(1), 109–116 (1999) · DOI · Paper page
- Smith P.R., Thornalley P.J.: Influence of pH and phosphate ions on the kinetics of enolisation and degradation of fructosamines. Studies with the model fructosamine, Nε-1-deoxy-D-fructos-1-yl hippuryllysine. Biochem Internat. 28(3), 429–439 (1992)
- Hustoft H.K., Reubsaet L., Greibrokk T., Lundanes E., Malerod H.: Critical assessment of accelerating trypsination methods. J Pharm Biomed Anal. 56(5), 1069–1078 (2011) · doi:10.1016/j.jpba.2011.08.013
- Schmidt R., Böhme D., Singer D., Frolov A.: Specific tandem mass spectrometric detection of AGE-modified arginine residues in peptides. J Mass Spectrom. 50(3), 613–624 (2015) · DOI
- Rabbani N., Thornalley P.J.: Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples. Nat Protoc. 9(8), 1969–1979 (2014) · DOI · Paper page
- Lo T.W.C., Westwood M.E., McLellan A.C., Selwood T., Thornalley P.J.: Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with Nα-acetylarginine, Nα-acetylcysteine, Nα-acetyl-lysine, and bovine serum albumin. J Biol Chem. 269(51), 32299–32305 (1994) · DOI · Paper page
- Leitner A., Lindner W.: Functional probing of arginine residues in proteins using mass spectrometry and an arginine-specific covalent tagging concept. Anal Chem. 77(14), 4481–4488 (2005) · DOI
- Leitner A., Amon S., Rizzi A., Lindner W.: Use of the arginine-specific butanedione/phenylboronic acid tag for analysis of peptides and protein digests using matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom. 21(7), 1321–1330 (2007) · doi:10.1002/rcm.2967
- Kilhovd B.K., Giardino I., Torjesen P.A., Birkeland K.I., Berg T.J., Thornalley P.J., Brownlee M., Hanssen K.F.: Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism. 52(2), 163–167 (2003) · DOI · Paper page
- Biemel K.M., Friedl D.A., Lederer M.O.: Identification and quantification of major Maillard cross-links in human serum albumin and lens protein - evidence for glucosepane as the dominant compound. J Biol Chem. 277(28), 24907–24915 (2002) · DOI · Paper page
- Dai Z., Wang B., Sun G., Fan X., Anderson V.E., Monnier V.M.: Identification of glucose-derived cross-linking sites in ribonuclease a. J Proteome Res. 7(7), 2756–2768 (2008) · DOI
Cited by
Advanced glycation end products in the pathogenesis of chronic kidney disease
Rabbani, N., & Thornalley, P. J. (2018) · Kidney International · doi:10.1016/j.kint.2017.11.034 · Cited by 387
Self-citationGlyoxalase 1 Modulation in Obesity and Diabetes
Rabbani, N., & Thornalley, P. J. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7424 · Cited by 102
Self-citationO’Grady, K. L., Khosla, S., Farr, J. N., Bondar, O. P., Atkinson, E. J., Achenbach, S. J., Eckhardt, B. A., Thicke, B. S., Tweed, A. J., Volkman, T. L., et al. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa023 · Cited by 19
Metadata
- Authors
- Rabbani, N., Ashour, A., & Thornalley, P. J.
- Venue
- Glycoconjugate Journal
- Published
- 2016-07-20
- Volume
- 33
- Issue
- 4
- Pages
- 553-568
- ISSN
- 0282-0080 (ISSN-L)
- 1573-4986
- OpenAlex
- W2470810595
- Cited by
- 98
- References
- 5
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mass spectrometric determination of early and advanced glycation in biology. https://app.cochat.ai/papers/10.1007/s10719-016-9709-8
- The paper
- Rabbani, N., Ashour, A., & Thornalley, P. J. (2016). Mass spectrometric determination of early and advanced glycation in biology. Glycoconjugate Journal. https://doi.org/10.1007/s10719-016-9709-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.